Please provide your email address to receive an email when new articles are posted on . Human GABAergic interneurons were implanted in two patients with drug-refractory focal epilepsy. Preliminary ...

After numerous face injuries, five facial reconstruction surgeries and three wrecked cars due to epilepsy, a University of Arkansas for Medical Sciences patient has received the first transplantation ...

Neurona Therapeutics and UCSF researchers have developed and characterized a cell therapy alternative to treat drug-resistant mesial temporal lobe epilepsy (MTLE), the most common type of focal ...

David Spencer, MD, director of the Comprehensive Epilepsy Center and professor of neurology at Oregon Health and Science University, discusses the importance of patient safety in a first-in-human ...

David Spencer, MD, director of the Comprehensive Epilepsy Center and professor of neurology at Oregon Health and Science University, talks about the first-in-human trial of interneuron cell therapy ...

Building upon preliminary efficacy and safety data from its ongoing Phase 1/2 trial in unilateral MTLE, most recently presented at the 2025 American Academy of Neurology (AAN) Annual Meeting, Neurona ...